|
TMPO expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.744600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.892600E-01 |
| Normal-vs-Stage2 |
1.309670E-02 |
| Normal-vs-Stage3 |
1.607780E-01 |
| Normal-vs-Stage4 |
2.187400E-01 |
| Stage1-vs-Stage2 |
2.503900E-02 |
| Stage1-vs-Stage3 |
4.141400E-01 |
| Stage1-vs-Stage4 |
5.600000E-01 |
| Stage2-vs-Stage3 |
1.170380E-01 |
| Stage2-vs-Stage4 |
1.466230E-01 |
| Stage3-vs-Stage4 |
9.695000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.298800E-01 |
| Normal-vs-AfricanAmerican |
9.986400E-01 |
| Normal-vs-Asian |
1.834180E-01 |
| Caucasian-vs-AfricanAmerican |
4.932400E-01 |
| Caucasian-vs-Asian |
4.518400E-01 |
| AfricanAmerican-vs-Asian |
3.369600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.583700E-02 |
| Normal-vs-Female |
3.027200E-01 |
| Male-vs-Female |
1.445570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.120800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.808300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.056570E-01 |
| Normal-vs-Age(81-100Yrs) |
5.481000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.487900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.830400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.759200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.732000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.250400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.276000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.071600E-01 |
| Classical-VS-Follicular |
2.81999978923864E-11 |
| Classical-VS-Other |
3.191800E-01 |
| Classical-VS-Normal |
9.215600E-01 |
| Tall-VS-Follicular |
5.256400E-03 |
| Tall-VS-Other |
7.465800E-01 |
| Tall-VS-Normal |
3.303400E-01 |
| Follicular-VS-Other |
2.395600E-01 |
| Follicular-VS-Normal |
1.66342999999847E-05 |
| Other-VS-Normal |
3.954200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.110200E-02 |
| Normal-vs-N1 |
9.266400E-02 |
| N0-vs-N1 |
7.465000E-01 |
|
|
